Cytokinetics Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€30.20
Target price
04.08.24
€54.39
Performance (%)
67.22%
End price
05.08.24
€50.50
Summary
This prediction ended on 05.08.24 with a price of €50.50. The BUY prediction by Morgan_Stanley for Cytokinetics Inc. saw massive gains of 67.22%. Morgan_Stanley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 3.810% | 3.810% | 18.996% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten